Document is current
Any future updates will be listed below
-
Authors
Levine, David M. https://orcid.org/0000-0002-4337-9896
Samal, Lipika
Neville, Bridget A.
Burdick, Elisabeth
Wien, Matthew
Rodriguez, Jorge A.
Ganesan, Sandya
Blitzer, Stephanie C.
Yuan, Nina H.
Ng, Kenney
Park, Yoonyoung
Rajmane, Amol
Jackson, Gretchen Purcell
Lipsitz, Stuart R.
Bates, David W.
-
Funding
Funding for this research was provided by:
International Business Machines Corporation
- License Information
-
More Information
Article History
Received: 28 December 2021
Accepted: 29 July 2022
First Online: 24 August 2022
Declarations
:
: • David Levine reports receiving funds from Biofourmis for a PI-initiated study and fees from The MetroHealth System, separate from the present work.• David Bates reports consulting for EarlySense, which makes patient safety monitoring systems. He also receives cash compensation from CDI-Negev Ltd., which is a not-for-profit incubator for health information technology start-ups. He receives equity from ValeraHealth, which makes software to help patients with chronic diseases; from Clew, which makes software to support clinical decision making in intensive care; and from MDClone, which produces deidentified versions of clinical data. He receives equity and cash compensation from FeelBetter.• Lipika Samal receives research funding from the National Institute of Diabetes and Digestive and Kidney Diseases (Grant No. R01DK116898). The views expressed in this article are those of the authors and do not necessarily reflect the views and policy of the National Institutes of Health.• Yoonyoung Park, Kenney Ng, Amol Rajmane, and Gretchen Purcell Jackson are employees of IBM Corporation.• All other authors have nothing to disclose.
Free to read: This content has been made available to all.
